Global Hba1c Testing Device Market Expected to Reach US$ 2082.6 Bn by 2026

October 03 11:50 2019
Global Hba1c Testing Device Market Expected to Reach US$ 2082.6 Bn by 2026
Global Hba1c Testing Device Market, By Device Type (Handheld and Benchtop), By technique (Ion Exchange Hplc, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay and Others), By End User (Diagnostic Labs and Clinics, Hospitals and Homecare settings) and Geography – Opportunities & Forecast, 2019-2026

The global  Hba1c Testing Device market was valued at USD 1040.9 million in 2018, and is projected to reach USD 2082.6 million by 2026, growing at a CAGR of 9.2% during 2019-2026. Growth in the market is being expected on the basis of factors, such as surging number of diabetes patients coupled with increasing rate of diagnosis, growing concern regarding risk free living, lifestyle, advancement in technology and spending on healthcare facilities across the globe. In addition, efficiency, cost effectiveness and being patient friendly are the factors which are major plus for the use of hba1c testing device in homecare settings, hospitals and diagnostic laboratories & clinics which are the end user segment

Based on Device type, Benchtop Device Segment is anticipated to lead the market during 2019-2026  

Benchtop Device segment is expected to capture maximum market share during the forecast period due to technological advancement in the field of medical device segment. However, the highest growth rate is predicted to be exhibited by handheld device segment during the forecast period owing to surging adoption of advanced and portable devices among healthcare professionals and patients due to their high accuracy and technological advancement. Additionally, wide availability of technically advanced equipment, products and services and treatment and rising demand for accurate and smart diagnosis is likely to push the growth of global Hba1c Testing Device market in the forecast years.

Request For Sample Report- https://www.gmiresearch.com/report/global-hba1c-testing-device-market-2019-2026/sample-request

Based on Technique, Turbidimetric Inhibition Immunoassay segment is anticipated to lead the market during 2019-2026
Turbidimetric Inhibition Immunoassay segment is expected to hold maximum share in the market during the forecast period due to its accuracy, cost effectiveness and fast speed. Others segment is projected to exhibit a high growth rate during the forecast period owing to continuous demand for better technique among the patients.

Based on End User, Diagnostic Labs and Clinics dominates the market, and is projected to grow at a significant rate during 2019-2026
Diagnostic Labs and Clinics segment is expected to lead the market in terms of maximum share during the forecast period due to advancement in the field of healthcare services. However, the highest growth rate is predicted to be exhibited by homecare setting segment during the forecast period owing to surging adoption of hba1c handheld testing device.

The companies are focusing on advanced hba1c testing technology to maintain their leadership in global Hba1c Testing Device market.

North America held the largest market share in global Hba1c Testing Device market in 2018 owing to the well-established healthcare infrastructure and advent of new technologies in diabetes management along with the rising awareness of diabetes among people. Rest of the World is predicted to have the highest growth rate in the forecast period. 

Various notable players operating in global Hba1c Testing Device market include Abbott Laboratories, Transasia Biomedicals Limited, Alere Incorporated, Arkray Incorporated , Danaher Co , Bio-Rad Laboratories , Siemens Healthcare , F.Hoffmann-La Roche, Trinity Biotech Plc and Bayer Healthcare among others.

The Global Hba1c Testing Device Market has been segmented on the basis of device type, technique, end user type and key geographies. Based on device type, the market comprises of Handheld and Benchtop Devices. The technique includes Ion Exchange Hplc, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay and Others. The end user includes Hospital, Homecare Setting and Diagnostic Laboratories & Clinics.

Request for Customization — https://www.gmiresearch.com/report/global-hba1c-testing-device-market-2019-2026/request-for-customization

The research report “Global Hba1c Testing Device Market ” provides in-depth analysis of the Hba1c Testing Device market, globally, based on device type, technique type, end user and major geographies for the forecast period from 2019 to 2026. The report underlines the major market drivers driving the market growth as well as challenges faced by the market participants. The research report provides market size and forecast for Hba1c Testing Device market. The Hba1c Testing Device analyses the competition in the market, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace is the Hba1c Testing Device market growing worldwide? What will be the growth trend in future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in global Hba1c Testing Device market?
4-    What are the various application areas and how they are poised to grow?

Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: Send Email
Phone: +353 1 442 8820
Address:Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate
City: Dublin
Country: Ireland
Website: www.gmiresearch.com

  Categories: